Kevin Fischbeck
Stock Analyst at B of A Securities
(4.12)
# 542
Out of 4,711 analysts
160
Total ratings
66.96%
Success rate
6.62%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Neutral | $247 → $308 | $247.10 | +24.65% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $16.01 | +18.68% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $500.13 | +29.97% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $22.94 | +109.24% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $1.97 | +52.28% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $151.85 | -4.51% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $365.96 | +44.82% | 3 | Jul 18, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $105 → $90 | $37.90 | +137.47% | 5 | May 2, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $294.73 | +48.95% | 15 | Apr 1, 2024 | |
| AHCO AdaptHealth | Downgrades: Underperform | $6.5 | $10.28 | -36.77% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $10.61 | -31.67% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $59.58 | +20.85% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $276.92 | +26.39% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $180.11 | +1.60% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.22 | +112.06% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $94.45 | -21.65% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $294 → $323 | $303.62 | +6.38% | 8 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.16 | +74.05% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $19.06 | +83.63% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.23 | +209.60% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $129.46 | -61.38% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $17.91 | -58.12% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $22.91 | -21.43% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.09 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $42.83 | -55.64% | 2 | Feb 9, 2018 |
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $247.10
Upside: +24.65%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $16.01
Upside: +18.68%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $500.13
Upside: +29.97%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $22.94
Upside: +109.24%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.97
Upside: +52.28%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $151.85
Upside: -4.51%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $365.96
Upside: +44.82%
Acadia Healthcare Company
May 2, 2024
Maintains: Buy
Price Target: $105 → $90
Current: $37.90
Upside: +137.47%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $294.73
Upside: +48.95%
AdaptHealth
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.28
Upside: -36.77%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $10.61
Upside: -31.67%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $59.58
Upside: +20.85%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $276.92
Upside: +26.39%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $180.11
Upside: +1.60%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.22
Upside: +112.06%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $94.45
Upside: -21.65%
Apr 24, 2023
Maintains: Buy
Price Target: $294 → $323
Current: $303.62
Upside: +6.38%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.16
Upside: +74.05%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $19.06
Upside: +83.63%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.23
Upside: +209.60%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $129.46
Upside: -61.38%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $17.91
Upside: -58.12%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $22.91
Upside: -21.43%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.09
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $42.83
Upside: -55.64%